Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine in a 12-week treatment study if MEM 1003 is a safe
and effective treatment for patients with mild to moderate Alzheimer's disease.